Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of inhibiting apoptosis or promoting cell survival by providing a bi-specific protein comprising insulin-like growth factor IGF-1 and Annexin A5

Method of inhibiting apoptosis or promoting cell survival by providing a bi-specific protein comprising insulin-like growth factor IGF-1 and Annexin A5

US Patent 11155593 · Granted Oct 26, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating skin tissue damage by topically administering a bi-specific p2024
Method of treating skin tissue damage by topically administering a bi-specific p2024
Method of treating skin tissue damage by topically administering a bi-specific p2024
Method of treating skin tissue damage by topically administering a bi-specific p2024
Method of treating skin tissue damage by topically administering a bi-specific p2024
Method of treating skin tissue damage by topically administering a bi-specific p2024
Method of treating skin tissue damage by topically administering a bi-specific p2024
Method of treating skin tissue damage by topically administering a bi-specific p2024
Activatable fusion protein and use thereof2024
Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nu2024
Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nu2024
Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nu2024